These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31820006)

  • 1. A review of the safety and clinical utility of contrast echocardiography.
    Chai SC; Tan PJ; Tong KL
    Singapore Med J; 2020 Apr; 61(4):181-183. PubMed ID: 31820006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound contrast agents: balancing safety versus efficacy.
    Main ML; Goldman JH; Grayburn PA
    Expert Opin Drug Saf; 2009 Jan; 8(1):49-56. PubMed ID: 19236217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration).
    Grayburn PA
    Am J Cardiol; 2008 Mar; 101(6):892-3. PubMed ID: 18328861
    [No Abstract]   [Full Text] [Related]  

  • 5. Contrast echocardiography: evidence for clinical use.
    Bhatia VK; Senior R
    J Am Soc Echocardiogr; 2008 May; 21(5):409-16. PubMed ID: 18329848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast echocardiography: beyond a black box warning?
    Lester SJ; Miller FA; Khandheria BK
    J Am Soc Echocardiogr; 2008 May; 21(5):417-8. PubMed ID: 18456157
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrast echocardiography: clinical utility for the evaluation of left ventricular systolic function.
    Lindner JR; Lewis C
    Am Heart Hosp J; 2004; 2(1):16-20. PubMed ID: 15604834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group.
    Shaw LJ; Gillam L; Feinstein S; Dent J; Plotnick G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP169-76. PubMed ID: 10185992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bubble trouble?
    ter Haar G
    Ultraschall Med; 2008 Oct; 29(5):550-1. PubMed ID: 18937172
    [No Abstract]   [Full Text] [Related]  

  • 10. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent.
    Exuzides A; Main ML; Colby C; Grayburn PA; Feinstein SB; Goldman JH
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):578-85. PubMed ID: 20541713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarction.
    Nucifora G; Marsan NA; Siebelink HM; van Werkhoven JM; Schuijf JD; Schalij MJ; Poldermans D; Holman ER; Bax JJ
    Eur J Echocardiogr; 2008 Nov; 9(6):816-8. PubMed ID: 18635517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse bioeffects of ultrasound contrast agents used in echocardiography: true safety issue or "much ado about nothing"?
    Aggeli C; Giannopoulos G; Lampropoulos K; Pitsavos C; Stefanadis C
    Curr Vasc Pharmacol; 2009 Jul; 7(3):338-46. PubMed ID: 19601858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).
    Main ML; Ryan AC; Davis TE; Albano MP; Kusnetzky LL; Hibberd M
    Am J Cardiol; 2008 Dec; 102(12):1742-6. PubMed ID: 19064035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of perflutren contrast agents during transthoracic echocardiography is not associated with a significant increase in acute mortality risk.
    Goldberg YH; Ginelli P; Siegel R; Ostfeld RJ; Schaefer M; Spevack DM
    Cardiology; 2012; 122(2):119-25. PubMed ID: 22813648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent.
    Main ML; Hibberd MG; Ryan A; Lowe TJ; Miller P; Bhat G
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):40-8. PubMed ID: 24290568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction.
    Lehman EP; Cowper PA; Randolph TC; Kosinski AS; Lopes RD; Douglas PS
    Am J Cardiol; 2018 Jul; 122(1):121-128. PubMed ID: 29753394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bubbles in Ballooning: Safety and Utility.
    Citro R; Lyon AR; Silverio A; Bossone E
    J Am Soc Echocardiogr; 2015 Jul; 28(7):845. PubMed ID: 25998692
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility contrast echocardiography in the emergency department.
    Wei K
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):197-203. PubMed ID: 20159647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies.
    Aggeli C; Giannopoulos G; Roussakis G; Christoforatou E; Marinos G; Toli C; Pitsavos C; Stefanadis C
    Heart; 2008 Dec; 94(12):1571-7. PubMed ID: 18474538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of telemedicine on the practice of pediatric cardiology in community hospitals.
    Sable CA; Cummings SD; Pearson GD; Schratz LM; Cross RC; Quivers ES; Rudra H; Martin GR
    Pediatrics; 2002 Jan; 109(1):E3. PubMed ID: 11773571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.